Cooper Companies Inc (COO)
COO on New York Consolidated
111.22USD
17 May 2013
111.22USD
17 May 2013
Price Change (% chg)
$0.70 (+0.63%)
$0.70 (+0.63%)
Prev Close
$110.52
$110.52
Open
$111.08
$111.08
Day's High
$111.61
$111.61
Day's Low
$110.80
$110.80
Volume
253,837
253,837
Avg. Vol
294,240
294,240
52-wk High
$116.79
$116.79
52-wk Low
$71.40
$71.40
About
The Cooper Companies, Inc. (Cooper) is a global medical products company that serves the specialty healthcare market through its two business units, CooperVision, Inc. (CVI) and CooperSurgical, Inc. (CSI). CVI develops, manufactures and markets a range of contact lenses for the global vision correction market. CVI specializes in... (more)
Overall
| Beta: | 0.88 |
| Market Cap (Mil.): | $5,373.66 |
| Shares Outstanding (Mil.): | 48.32 |
| Dividend: | 0.03 |
| Yield (%): | 0.05 |
Financials
| COO | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 20.42 | 30.63 | 35.83 |
| EPS (TTM): | 5.45 | -- | -- |
| ROI: | 10.51 | 10.42 | 18.72 |
| ROE: | 12.87 | 13.40 | 19.54 |
BRIEF-Cooper shares down 1.7 percent after the bell
NEW YORK, Dec 6 - Cooper Companies Inc : * Shares were down 1.7 percent after the bell following the release of its results.
Competitors
| Price | Change | |
|---|---|---|
| Johnson & Johnson (JNJ.N) | $88.09 | +0.64 |
| Novartis AG (NOVN.VX) | CHF71.75 | -0.45 |
| Covidien plc (COV.N) | $65.77 | +0.10 |
| Boston Scientific Corporation (BSX.N) | $9.10 | +0.06 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Trading Report for (COO). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: S&P Capital IQ – STARS Reports
|
$115.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

